Show simple item record

The future of Extracellular Vesicles as Theranostics - an ISEV meeting report

dc.contributor.authorO'Driscoll, Lorraine
dc.contributor.authorSoekmadji, Carolina
dc.contributor.authorLi, Bo
dc.contributor.authorHuang, Yiyao
dc.contributor.authorWang, Haifang
dc.contributor.authorAn, Taixue
dc.contributor.authorLiu, Chunchen
dc.contributor.authorPan, Weilun
dc.contributor.authorChen, Jing
dc.contributor.authorCheung, Lesley
dc.contributor.authorFalcon-Perez, Juan Manuel
dc.contributor.authorGho, Yong Song
dc.contributor.authorHolthofer, Harry B.
dc.contributor.authorLe, Minh T.N.
dc.contributor.authorMarcilla, Antonio
dc.contributor.authorShekari, Faezeh
dc.contributor.authorShen, Tang Long
dc.contributor.authorTorrecilhas, Ana Claudia
dc.contributor.authorYan, Xiaomei
dc.contributor.authorYang, Fuquan
dc.contributor.authorYin, Hang
dc.contributor.authorXiao, Yu
dc.contributor.authorZhao, Zezhou
dc.contributor.authorZou, Xue
dc.contributor.authorWang, Qian
dc.contributor.authorZheng, Lei
dc.date.accessioned2020-09-04T16:07:09Z
dc.date.available2020-09-04T16:07:09Z
dc.date.issued2020
dc.date.submitted2020en
dc.identifier.citationSoekmadji C, Li B, Huang Y, Wang H, An T, Liu C, Pan W, Chen J. Cheung L, Falcon-Perez JM, Song Gho Y, Holthofer HB, Le MT, Marcilla A, O'Driscoll L, Shekari F, Shen TL, Torrecilhas AC, Yan X, Yang F, Yin H, Xiao Y, Zhao Z, Zou X, Wang Q, Zheng L., The future of Extracellular Vesicles as Theranostics - an ISEV meeting report, J. Extracellular Vesicles, 9, 1, 2020en
dc.identifier.otherY
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1080/20013078.2020.1809766
dc.identifier.urihttp://hdl.handle.net/2262/93354
dc.description.abstractThe utilization of extracellular vesicles (EVs) in clinical theranostics has rapidly advanced in the past decade. In November 2018, the International Society for Extracellular Vesicles (ISEV) held a workshop on “EVs in Clinical Theranostic”. Here, we report the conclusions of roundtable discussions on the current advancement in the analysis technologies and we provide some guidelines to researchers in the field to consider the use of EVs in clinical application. The main challenges and the requirements for EV separation and characterization strategies, quality control and clinical investigation were discussed to promote the application of EVs in future clinical studies.en
dc.language.isoenen
dc.relation.ispartofseriesJ. Extracellular Vesicles;
dc.relation.ispartofseries9;
dc.relation.ispartofseries1;
dc.rightsYen
dc.subjectExtracellular vesiclesen
dc.subjectBiomarkeren
dc.subjectTherapyen
dc.subjectTheranosticen
dc.titleThe future of Extracellular Vesicles as Theranostics - an ISEV meeting reporten
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/lodrisc
dc.identifier.rssinternalid219943
dc.identifier.doi10.1080/20013078.2020.1809766
dc.rights.ecaccessrightsopenAccess
dc.subject.TCDThemeCanceren
dc.subject.TCDTagCANCERen
dc.subject.TCDTagExtracellular Vesiclesen
dc.subject.TCDTagExtracellular vesicles (EVs)en
dc.identifier.orcid_id0000-0002-9860-8262
dc.status.accessibleNen


Files in this item

Thumbnail
Name:
JEV__Future of EVs as Theranos ...
Size:
641.3Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record